Kevin Gregory Fuller
Known title: Global Chief Marketing OfficerCIK: 0002039631
Associated companies
Transaction History
| NATR | ▲ Buy | Grant | 8,984 | $0 | 5/15/2026 | View on chart |
| NATR | ▲ Buy | Option Exercise | 1,677 | $0 | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 573 | $15K | 5/5/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,497 | $38K | 3/10/2026 | View on chart |
| NATR | ▼ Sell | Other | 7,965 | — | 3/6/2026 | View on chart |
| NATR | ▲ Buy | Grant | 7,965 | $200K | 3/6/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 1,261 | $20K | 9/26/2025 | View on chart |
| NATR | ▲ Buy | Grant | 13,148 | $194K | 3/10/2025 | View on chart |
| NATR | ▲ Buy | Grant | 11,070 | $0 | 9/26/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.